Regeneron Pharmaceuticals (NasdaqGS:REGN) Update / Briefing November 10, 2025 08:30 AM ET Company ParticipantsGeoff Meacham - Managing DirectorBrian Abrahams - Managing Director and Global Sector HeadRyan Crowe - SVP of Investor RelationsL. Andres Sirulnik - SVP and Clinical Development Unit HeadGeorge Yancopoulos - President and Chief Scientific OfficerDave Reisinger - Responsible for Diversified Biopharma ResearchEvan Seigerman - Managing Director and Head of Healthcare ResearchSimon Baker - Head of Globa ...